المؤلفون: Iraola, Josu, O'Reilly, Maeve, Menne, Tobias, Kwon, Mi, IACOBONI, GLORIA, Navarro Garces, Victor, Barba, Pere, Abrisqueta, Pau

المساهمون: Institut Català de la Salut, Iacoboni G, Barba P, Abrisqueta P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Iraola‐Truchuelo J Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. O’Reilly M Department of Hematology, University College London Hospitals, London, UK. Navarro V Oncology Data Science (ODySey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Menne T Department of Hematology, Freeman Hospital, Newcastle, UK. Kwon M Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Avaluació de resultats (Assistència sanitària), Cèl·lules T - Ús terapèutic, Cèl·lules B - Tumors - Tractament, Limfomes - Tractament, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, DISEASES::Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse, Other subheadings::Other subheadings::Other subheadings::/drug therapy, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva

وصف الملف: application/pdf

العلاقة: HemaSphere;8(5); https://doi.org/10.1002/hem3.62Test; Iacoboni G, Iraola-Truchuelo J, O’Reilly M, Navarro V, Menne T, Kwon M, et al. Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy. HemaSphere. 2024 May 21;8(5):e62.; https://hdl.handle.net/11351/11604Test; 001228138800001

الإتاحة: https://doi.org/10.1002/hem3.62Test
https://hdl.handle.net/11351/11604Test

المؤلفون: Hansen, Doris, Bachy, Emmanuel, bansal, radhika, Rejeski, Kai, Wang, Yucai, IACOBONI, GLORIA, Barba, Pere

المساهمون: Institut Català de la Salut, Rejeski K Department of Medicine III – Hematology/Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK), Munich and Berlin Sites, and German Cancer Research Center, Heidelberg, Germany. Adult BMT and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY. Wang Y, Bansal R Division of Hematology, Mayo Clinic, Rochester, MN. Hansen DK Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL. Iacoboni G, Barba P Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Bachy E Department of Hematology, Lyon Sud Hospital, INSERM 1052, Pierre-Bénite, France, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cèl·lules T - Ús terapèutic, Cèl·lules B - Tumors, Neutropènia, Mieloma múltiple, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Plasma Cell, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Immunologic Techniques::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive, DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases::Leukocyte Disorders::Leukopenia::Agranulocytosis::Neutropenia, DISEASES::Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células plasmáticas, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::técnicas inmunológicas::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::linfoma::linfoma no Hodgkin::linfoma de células B, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas::trastornos leucocitarios::leucopenia::agranulocitosis::neutropenia

وصف الملف: application/pdf

العلاقة: Blood Advances;8(8); https://doi.org/10.1182/bloodadvances.2023011767Test; Rejeski K, Wang Y, Hansen DK, Iacoboni G, Bachy E, Bansal R, et al. Applying the EHA/EBMT Grading for ICAHT after CAR-T: Comparative Incidence and Association with Infections and Mortality. Blood Adv. 2024 Apr 23;8(8):1857–1868.; https://hdl.handle.net/11351/11330Test

الإتاحة: https://doi.org/10.1182/bloodadvances.2023011767Test
https://hdl.handle.net/11351/11330Test

المؤلفون: León-Román, Juan, Bolufer Cardona, Monica, Sánchez-Salinas, Mario, Alonso-Martínez, Carla, Bestard, Oriol, IACOBONI, GLORIA, Bermejo García, Sheila, Cecilia del Carmen, Carpio Segura, Garcia-Carro, Clara, Barba, Pere, Soler, María José

المساهمون: Institut Català de la Salut, León-Román J, Bermejo S, Bolufer M, Bestard O, Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CSUR National Unit of Expertise for Complex Glomerular Diseases of Spain, Barcelona, Spain. Iacoboni G Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Carpio C, Sánchez-Salinas M, Barba P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. García-Carro C Nephrology Department, San Carlos Clinical University Hospital, Madrid, Spain. Alonso-Martínez C Servei de Farmàcia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cèl·lules T - Ús terapèutic, Sang - Malalties - Tractament, Ronyons - Malalties - Complicacions, DISEASES::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Acute Kidney Injury, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Cell- and Tissue-Based Therapy, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Artificial::Receptors, Chimeric Antigen, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, ENFERMEDADES::enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::insuficiencia renal::lesión renal aguda, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::tratamientos basados en células y tejidos, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores artificiales::receptores de antígenos quiméricos, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas

وصف الملف: application/pdf

العلاقة: Clinical Kidney Journal;17(3); https://doi.org/10.1093/ckj/sfae027Test; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI21%2F01292; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/AC22%2F00029; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/RD21%2F0005%2F0016; León-Román J, Iacoboni G, Bermejo S, Carpio C, Bolufer M, García-Carro C, et al. Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies. Clin Kidney J. 2024 Mar;17(3):27.; https://hdl.handle.net/11351/11224Test

الإتاحة: https://doi.org/10.1093/ckj/sfae027Test
https://hdl.handle.net/11351/11224Test

المؤلفون: Minga, Eva, Chamou, Dimitra, Chatzikonstantinou, Thomas, Scarfo', Lydia, KARAKATSOULIS, GEORGIOS, IACOBONI, GLORIA

المساهمون: Institut Català de la Salut, Chatzikonstantinou T, Minga E, Chamou D Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. Scarfò L Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy. Karakatsoulis G Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. Department of Mathematics, University of Ioannina, Ioannina, Greece. Iacoboni G Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Leucèmia limfocítica crònica, Càncer - Factors de risc, DISEASES::Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Leukemia, Lymphoid::Leukemia, B-Cell::Leukemia, Lymphocytic, Chronic, B-Cell, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors, DISEASES::Neoplasms::Neoplasms, Second Primary, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::leucemia linfoide::leucemia de células B::leucemia linfocítica crónica de células B, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::estadística como asunto::probabilidad::riesgo::factores de riesgo, ENFERMEDADES::neoplasias::neoplasias primarias secundarias

وصف الملف: application/pdf

العلاقة: eClinicalMedicine;65; https://doi.org/10.1016/j.eclinm.2023.102307Test; Chatzikonstantinou T, Scarfò L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, et al. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. eClinicalMedicine. 2023 Nov;65:102307.; https://hdl.handle.net/11351/10847Test

الإتاحة: https://doi.org/10.1016/j.eclinm.2023.102307Test
https://hdl.handle.net/11351/10847Test

المؤلفون: Busch, Galina, Baumann, Stephan, Jitschin, Regina, Iraola, Josu, Blumenberg , Viktoria, IACOBONI, GLORIA, Gallur, Laura, Barba, Pere

المساهمون: Institut Català de la Salut, Blumenberg V Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany. German Cancer Consortium (DKTK), partner site Munich, Munich, Germany. Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany. Busch G, Baumann S Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany. Jitschin R Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany. Department for Hematology and Oncology, Otto-von-Guericke University, Magdeburg, Germany. Iacoboni G, Gallur L, Barba P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Iraola-Truchuelo J Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cèl·lules B - Tumors, Limfomes, Cèl·lules T, Antígens - Receptors, DISEASES::Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cell Separation::Flow Cytometry, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Immunologic::Receptors, Antigen::Receptors, Antigen, T-Cell, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::técnicas de laboratorio clínico::técnicas citológicas::separación celular::citometría de flujo, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores inmunológicos::receptores de antígenos::receptores de antígenos de linfocitos T

وصف الملف: application/pdf

العلاقة: Blood Advances;7(22); https://doi.org/10.1182/bloodadvances.2023010364Test; Blumenberg V, Busch G, Baumann S, Jitschin R, Iacoboni G, Gallur L, et al. Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL. Blood Adv. 2023 Nov 28;7(22):6844–9.; https://hdl.handle.net/11351/10816Test; 001113825800001

الإتاحة: https://doi.org/10.1182/bloodadvances.2023010364Test
https://hdl.handle.net/11351/10816Test

المؤلفون: Wang, Yucai, albanyan, omar, Munoz, Javier, Rejeski, Kai, SESQUES, Pierre, IACOBONI, GLORIA, Barba, Pere

المساهمون: Institut Català de la Salut, Rejeski K Department of Medicine III – Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany. Wang Y Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA. Albanyan O Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida, USA. Munoz J Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA. Sesques P Hospices Civils de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, Pierre-Bénite, France. Iacoboni G Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Department of Medicine, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Barba P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Limfomes - Tractament, Trastorns limfoproliferatius - Tractament, Cèl·lules T - Ús terapèutic - Efectes secundaris, DISEASES::Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, Mantle-Cell, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive, Other subheadings::Other subheadings::Other subheadings::/adverse effects, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::linfoma::linfoma no Hodgkin::linfoma de células del manto, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva, Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos

وصف الملف: application/pdf

العلاقة: American Journal of Hematology;98(11); https://doi.org/10.1002/ajh.27056Test; Rejeski K, Wang Y, Albanyan O, Munoz J, Sesques P, Iacoboni G, et al. The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL. Am J Hematol. 2023 Nov;98(11):1699–710.; https://hdl.handle.net/11351/10464Test; 001051772500001

الإتاحة: https://doi.org/10.1002/ajh.27056Test
https://hdl.handle.net/11351/10464Test

المؤلفون: Perez, Ariel, Blumenberg , Viktoria, Bücklein, Veit, Völkl, Simon, Rejeski, Kai, IACOBONI, GLORIA, Barba, Pere

المساهمون: Institut Català de la Salut, Rejeski K, Blumenberg V, Bücklein VL Department of Medicine III – Hematology/Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK), Munich and Berlin sites, and German Cancer Research Center, Heidelberg, Germany. Bavarian Cancer Research Center (BZKF), partner sites, Munich and Erlangen, Germany. Perez A Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA. Blood and Marrow Transplant Program, Miami Cancer Institute, Miami, FL, USA. Iacoboni G, Barba P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Völkl S Bavarian Cancer Research Center (BZKF), partner sites, Munich and Erlangen, Germany. Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Càncer, Immunoteràpia, Cèl·lules T, Antígens CD, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive, Other subheadings::Other subheadings::Other subheadings::/adverse effects, DISEASES::Neoplasms, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva, Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos, ENFERMEDADES::neoplasias

وصف الملف: application/pdf

العلاقة: Science Advances;9(38); https://doi.org/10.1126/sciadv.adg3919Test; Rejeski K, Perez A, Iacoboni G, Blumenberg V, Bücklein VL, Völkl S, et al. Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Sci Adv. 2023 Sep 22;9(38):eadg3919.; https://hdl.handle.net/11351/10382Test

الإتاحة: https://doi.org/10.1126/sciadv.adg3919Test
https://hdl.handle.net/11351/10382Test

المؤلفون: Perez, Ariel, Jurinovic, Vindi, Holtick, Udo, Rejeski, Kai, IACOBONI, GLORIA, Bücklein, Veit

المساهمون: Institut Català de la Salut, Bücklein V Department of Medicine III, University Hospital, LMU Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. Perez A Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA. Blood and Marrow Transplant Program, Miami Cancer Institute, Miami, FL, USA. Rejeski K Department of Medicine III, University Hospital, LMU Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK) Munich Site, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Iacoboni G Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Jurinovic V Institute for Medical Information Processing, Biometry, and Epidemiology, LMU Munich, Germany. Holtick U Department I of Internal Medicine, Medical Faculty and University Hospital, Cologne, University of Cologne, Germany, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cèl·lules B - Tumors - Immunoteràpia, Avaluació de resultats (Assistència sanitària), DISEASES::Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell, Other subheadings::Other subheadings::/therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::linfoma::linfoma no Hodgkin::linfoma de células B, Otros calificadores::Otros calificadores::/terapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento

وصف الملف: application/pdf

العلاقة: HemaSphere;7(8); https://doi.org/10.1097/HS9.0000000000000907Test; Bücklein V, Perez A, Rejeski K, Iacoboni G, Jurinovic V, Holtick U, et al. Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use. HemaSphere. 2023 Jul 11;7(8):e907.; https://hdl.handle.net/11351/10105Test; 001029914500001

الإتاحة: https://doi.org/10.1097/HS9.0000000000000907Test
https://hdl.handle.net/11351/10105Test

المؤلفون: Bosch-Schips, Jan, Serna, Angel, Abrisqueta, Pau, Nadeu, Ferran, IACOBONI, GLORIA, Cabirta, Alba, Bosch, Francesc

المساهمون: Institut Català de la Salut, Abrisqueta P, Iacoboni G, Serna A, Cabirta A, Bosch F Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Nadeu F Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Department of Pathology, Hospital Universitari de Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. Bosch-Schips J Department of Pathology, Hospital Universitari de Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Leucèmia limfocítica crònica - Complicacions, Trastorns limfoproliferatius - Tractament, DISEASES::Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia, Lymphoid::Leukemia, B-Cell::Leukemia, Lymphocytic, Chronic, B-Cell, Other subheadings::Other subheadings::Other subheadings::/complications, DISEASES::Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse, Other subheadings::Other subheadings::/therapy, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::leucemia::leucemia linfoide::leucemia de células B::leucemia linfocítica crónica de células B, Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso, Otros calificadores::Otros calificadores::/terapia

وصف الملف: application/pdf

العلاقة: Cancer Treatment Reviews;120; https://doi.org/10.1016/j.ctrv.2023.102619Test; info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F01392; Abrisqueta P, Nadeu F, Bosch-Schips J, Iacoboni G, Serna A, Cabirta A, et al. From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia. Cancer Treat Rev. 2023 Nov;120:102619.; https://hdl.handle.net/11351/10286Test

الإتاحة: https://doi.org/10.1016/j.ctrv.2023.102619Test
https://hdl.handle.net/11351/10286Test

المؤلفون: Blumenberg, Viktoria, Iacoboni García-Calvo, Gloria, Kharboutli, Soraya, Hernani, Rafael, Barba Suñol, Pere, Lopez Corral, Lucia, Rejeski, Kai

المساهمون: Institut Català de la Salut, Rejeski K, Blumenberg V Department of Medicine III – Hematology/Oncology, University Hospital, LMU Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany. Bavarian Cancer Research Center (BZKF), Partner Sites Munich and Erlangen, Germany. Iacoboni G, Barba P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament of Medicina, Universitat Autònoma of Barcelona, Bellaterra, Spain. Lopez-Corral L Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain. Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain. Kharboutli S Bavarian Cancer Research Center (BZKF), Partner Sites Munich and Erlangen, Germany. Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Germany. Hernani R Hematology Department, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cèl·lules B - Tumors - Tractament, Cèl·lules T - Receptors, ANATOMY::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Artificial::Receptors, Chimeric Antigen, DISEASES::Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse, Other subheadings::Other subheadings::/therapy, ANATOMÍA::células::células sanguíneas::leucocitos::leucocitos mononucleares::linfocitos::linfocitos T, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores artificiales::receptores de antígenos quiméricos, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso, Otros calificadores::Otros calificadores::/terapia

وصف الملف: application/pdf

العلاقة: HemaSphere;7(4); http://dx.doi.org/10.1097/HS9.0000000000000858Test; Rejeski K, Blumenberg V, Iacoboni G, Lopez-Corral L, Kharboutli S, Hernani R, et al. Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL. HemaSphere. 2023 Apr;7(4):e858.; https://hdl.handle.net/11351/9433Test

الإتاحة: https://doi.org/10.1097/HS9.0000000000000858Test
https://hdl.handle.net/11351/9433Test